CervoMed Inc. Files 8-K with Regulatory Updates
Ticker: CRVO · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-disclosure, corporate-events
TL;DR
CervoMed filed an 8-K on April 7th detailing events from April 2nd, including regulatory and financial updates.
AI Summary
CervoMed Inc. filed an 8-K on April 7, 2025, reporting events that occurred on April 2, 2025. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Diffusion Pharmaceuticals Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This 8-K filing provides important updates on CervoMed's regulatory disclosures and other corporate events, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting routine corporate events and disclosures, not indicating any immediate financial distress or significant operational changes.
Key Numbers
- 001-37942 — Commission File Number (Identifies the company's SEC filing record.)
- 30-0645032 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Diffusion Pharmaceuticals Inc. (company) — Former company name
- 20 Park Plaza, Suite 424 Boston, Massachusetts 02116 (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What specific events are detailed under 'Other Events' in this 8-K filing?
The provided text does not specify the details of the 'Other Events'; it only lists it as an item reported in the 8-K.
When was CervoMed Inc. formerly known as Diffusion Pharmaceuticals Inc.?
The filing indicates the date of the name change from Diffusion Pharmaceuticals Inc. was 20160115.
What is the SIC code for CervoMed Inc.?
The Standard Industrial Classification (SIC) code for CervoMed Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the primary business address of CervoMed Inc.?
The primary business address is 20 Park Plaza, Suite 424, Boston, Massachusetts 02116.
What is the fiscal year end for CervoMed Inc.?
The fiscal year end for CervoMed Inc. is December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding CervoMed Inc. (CRVO).